Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXELIXIS, INC.EXEL · Entity 3386 | Director | January 03, 2020 | April 14, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXELIXIS, INC.
Report date January 03, 2020 · Filed April 14, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 256,278 |
Ending reported balance
After 2019-12-12 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2019-12-12 · Gift · Disposed 1,699 · Balance 259,676 F1: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Row 2 · 2019-12-12 · Gift · Disposed 1,699 · Balance 257,977 F1: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Row 3 · 2019-12-12 · Gift · Disposed 1,699 · Balance 256,278 F1: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2021 Filed Jul 8, 2021 23:45 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $6.30 | $0.00 |
DisclosureSEC source: 0000939767-21-000071 · wf-form4_162578790212808.xml · derivative · entry 4 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2023-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 26, 2016. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 23:45 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0000939767-21-000071 · wf-form4_162578790212808.xml · derivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2022-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 28, 2015. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 23:45 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $6.30 | $252,000.00 |
DisclosureSEC source: 0000939767-21-000071 · wf-form4_162578790212808.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 23:45 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $3.13 | $125,200.00 |
DisclosureSEC source: 0000939767-21-000071 · wf-form4_162578790212808.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2021 Filed May 29, 2021 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 33,549 | $0.00 Strike: $22.48 | $0.00 |
DisclosureSEC source: 0000939767-21-000061 · wf-form4_162224756375597.xml · derivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,549 Underlying: Common Stock · 33,549 shares Expires 2028-05-26 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0000939767-21-000026 · wf-form4_161438823233506.xml · derivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2021-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 40,000 | $22.69 | $907,600.00 |
DisclosureSEC source: 0000939767-21-000026 · wf-form4_161438823233506.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,375 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.57 to $22.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 40,000 | $3.38 | $135,200.00 |
DisclosureSEC source: 0000939767-21-000026 · wf-form4_161438823233506.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2021 Filed Apr 14, 2022 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 1,403 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000047 · wf-form5_164989554990820.xml · nonDerivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,530 F1 · kind: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Read SEC document |
| January 05, 2021 Filed Apr 14, 2022 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 1,403 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000047 · wf-form5_164989554990820.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,933 F1 · kind: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Read SEC document |
| January 05, 2021 Filed Apr 14, 2022 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 1,403 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000047 · wf-form5_164989554990820.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,336 F1 · kind: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 00:05 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 115,396 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0000939767-20-000121 · wf-form4_159917791684326.xml · derivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 115,396 shares Expires 2020-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 115,396 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013. Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 00:05 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 115,396 | $5.82 | $671,604.72 |
DisclosureSEC source: 0000939767-20-000121 · wf-form4_159917791684326.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 23, 2020 00:57 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 30,750 | $0.00 Strike: $24.62 | $0.00 |
DisclosureSEC source: 0000939767-20-000094 · wf-form4_159019545539202.xml · derivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,750 Underlying: Common Stock · 30,750 shares Expires 2027-05-20 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 02:14 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0000939767-20-000040 · wf-form4_158320162469177.xml · derivative · entry 4 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2010. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 02:14 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.58 | $0.00 |
DisclosureSEC source: 0000939767-20-000040 · wf-form4_158320162469177.xml · derivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 02:14 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $5.92 | $88,800.00 |
DisclosureSEC source: 0000939767-20-000040 · wf-form4_158320162469177.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 02:14 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 30,000 | $4.58 | $137,400.00 |
DisclosureSEC source: 0000939767-20-000040 · wf-form4_158320162469177.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2020 Filed Apr 14, 2022 00:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 1,513 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000048 · wf-form5_164989562478492.xml · nonDerivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,739 F1 · kind: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Read SEC document |
| January 17, 2020 Filed Apr 14, 2022 00:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 1,513 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000048 · wf-form5_164989562478492.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,252 F1 · kind: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Read SEC document |
| January 17, 2020 Filed Apr 14, 2022 00:20 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 1,513 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000048 · wf-form5_164989562478492.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,765 F1 · kind: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Read SEC document |
| December 12, 2019 Filed Apr 14, 2022 00:21 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 1,699 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000049 · wf-form5_164989570305374.xml · nonDerivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,278 F1 · kind: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Read SEC document |
| December 12, 2019 Filed Apr 14, 2022 00:21 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 1,699 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000049 · wf-form5_164989570305374.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,977 F1 · kind: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Read SEC document |
| December 12, 2019 Filed Apr 14, 2022 00:21 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GiftCommon Stock | 1,699 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-22-000049 · wf-form5_164989570305374.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,676 F1 · kind: Prior Forms 4 after the date of the gift did not reflect this gift in reporting the number of shares held after the transaction(s) specified in the applicable Form 4. Read SEC document |
| May 23, 2019 Filed May 25, 2019 00:32 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 42,641 | $0.00 Strike: $19.77 | $0.00 |
DisclosureSEC source: 0000939767-19-000130 · wf-form4_155874434720088.xml · derivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,641 Underlying: Common Stock · 42,641 shares Expires 2026-05-22 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 100% of the shares subject to the option on the first anniversary of the date of grant, subject to the Reporting Person's continuous service through such date. Read SEC document |
| February 25, 2019 Filed Feb 28, 2019 01:30 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0000939767-19-000052 · wf-form4_155131741145981.xml · derivative · entry 5 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012. Read SEC document |
| February 25, 2019 Filed Feb 28, 2019 01:30 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 11,250 | $0.00 Strike: $4.16 | $0.00 |
DisclosureSEC source: 0000939767-19-000052 · wf-form4_155131741145981.xml · derivative · entry 4 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires 2019-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 11,250 shares of Exelixis, Inc. common stock, became fully exercisable on May 14, 2009. Read SEC document |
| February 25, 2019 Filed Feb 28, 2019 01:30 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 5,271 | $22.18 | $116,910.78 |
DisclosureSEC source: 0000939767-19-000052 · wf-form4_155131741145981.xml · nonDerivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,979 Read SEC document |
| February 25, 2019 Filed Feb 28, 2019 01:30 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $4.57 | $68,550.00 |
DisclosureSEC source: 0000939767-19-000052 · wf-form4_155131741145981.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2019 Filed Feb 28, 2019 01:30 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 11,250 | $4.16 | $46,800.00 |
DisclosureSEC source: 0000939767-19-000052 · wf-form4_155131741145981.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2019 Filed Feb 20, 2019 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 48,180 | $21.48 | $1,034,906.40 |
DisclosureSEC source: 0000939767-19-000031 · wf-form4_155062501418461.xml · nonDerivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.22 to $22.11. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 100,000 | $22.19 | $2,219,000.00 |
DisclosureSEC source: 0000939767-19-000031 · wf-form4_155062501418461.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,180 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.02 to $22.62. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| February 14, 2019 Filed Feb 20, 2019 01:10 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 100,000 | $22.41 | $2,241,000.00 |
DisclosureSEC source: 0000939767-19-000031 · wf-form4_155062501418461.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,180 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.27 to $22.65. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| May 24, 2018 Filed May 25, 2018 00:19 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 31,167 | $0.00 Strike: $20.50 | $0.00 |
DisclosureSEC source: 0000939767-18-000102 · wf-form4_152720756339039.xml · derivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,167 Underlying: Common Stock · 31,167 shares Expires 2025-05-23 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:03 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $11.66 | $0.00 |
DisclosureSEC source: 0000939767-18-000079 · wf-form4_152599694362246.xml · derivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:03 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 15,000 | $21.42 | $321,300.00 |
DisclosureSEC source: 0000939767-18-000079 · wf-form4_152599694362246.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,180 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.41 to $21.47. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| May 09, 2018 Filed May 11, 2018 00:03 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $11.66 | $174,900.00 |
DisclosureSEC source: 0000939767-18-000079 · wf-form4_152599694362246.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:25 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.97 | $0.00 |
DisclosureSEC source: 0000939767-18-000039 · wf-form4_152046870216096.xml · derivative · entry 3 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:25 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 15,000 | $24.23 | $363,450.00 |
DisclosureSEC source: 0000939767-18-000039 · wf-form4_152046870216096.xml · nonDerivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,180 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $24.15 to $24.39. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
| March 05, 2018 Filed Mar 8, 2018 00:25 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 15,000 | $7.97 | $119,550.00 |
DisclosureSEC source: 0000939767-18-000039 · wf-form4_152046870216096.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2017 Filed May 27, 2017 00:45 UTC | EXELIXIS, INC. EXEL · Entity 3386 | GrantOption (right to buy) · Derivative | 23,491 | $0.00 Strike: $19.57 | $0.00 |
DisclosureSEC source: 0000939767-17-000108 · wf-form4_149584592558776.xml · derivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,491 Underlying: Common Stock · 23,491 shares Expires 2024-05-24 F1 · derivative.exercise_date: Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The option is exercisable immediately, subject to repurchase provisions, and will vest as to 1/12th of the shares subject to the option each month following the date of grant, subject to the Reporting Person's continuous service through such dates. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 00:15 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionOption (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0000939767-17-000049 · wf-form4_149074654060658.xml · derivative · entry 2 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 10,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2007. Read SEC document |
| March 27, 2017 Filed Mar 29, 2017 00:15 UTC | EXELIXIS, INC. EXEL · Entity 3386 | Exercise / conversionCommon Stock | 10,000 | $10.53 | $105,300.00 |
DisclosureSEC source: 0000939767-17-000049 · wf-form4_149074654060658.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 00:12 UTC | EXELIXIS, INC. EXEL · Entity 3386 | SaleCommon Stock | 10,000 | $21.82 | $218,200.00 |
DisclosureSEC source: 0000939767-17-000035 · wf-form4_148953671883702.xml · nonDerivative · entry 1 COHEN CHARLES · CIK 0001202089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,180 F1 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.81 to $21.83. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 1 to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.